Search results
-
Positive on Mphasis, Infosys; Recommend Alembic Pharma: Abhimanyu Sofat, IIFL�
Positive on Mphasis, Infosys; Recommend Alembic Pharma: Abhimanyu Sofat, IIFL� As a … the earnings growth is expected to be pretty good.?In the pharma space, despite the correction, we are not that … Sun Pharma as of now.?We would prefer some of the mid-cap stocks.?We have been recommending Alembic Pharma where we …
-
Positive on Mphasis, Infosys; Recommend Alembic Pharma: Abhimanyu Sofat, IIFL�
Positive on Mphasis, Infosys; Recommend Alembic Pharma: Abhimanyu Sofat, IIFL� As a … the earnings growth is expected to be pretty good.?In the pharma space, despite the correction, we are not that … Sun Pharma as of now.?We would prefer some of the mid-cap stocks.?We have been recommending Alembic Pharma where we …
-
Betting on IT and pharma midcap stocks: Abhimanyu Sofat, IIFL
Betting on IT and pharma midcap stocks: Abhimanyu Sofat, IIFL Infosys … a clarification soon.? What are your views on Sun Pharma We would like to see more numbers coming up …
-
Betting on IT and pharma midcap stocks: Abhimanyu Sofat, IIFL
Betting on IT and pharma midcap stocks: Abhimanyu Sofat, IIFL Infosys … a clarification soon.? What are your views on Sun Pharma We would like to see more numbers coming up …
-
Not IT, pharma or metal, this stock to gain most from Re fall: Abhimanyu Sofat, IIFL
Not IT, pharma or metal, this stock to gain most from Re fall: … ET Now. Edited excerpts:? Are IT and pharma the only story now or should one seriously look at … also playing well.? I would say that in addition to stocks like Aurobindo Pharma, where the acquisition of …
-
Not IT, pharma or metal, this stock to gain most from Re fall: Abhimanyu Sofat, IIFL
Not IT, pharma or metal, this stock to gain most from Re fall: … ET Now. Edited excerpts:? Are IT and pharma the only story now or should one seriously look at … also playing well.? I would say that in addition to stocks like Aurobindo Pharma, where the acquisition of …
-
Bullish on these 2 stocks in defence sector: Sanjiv Bhasin, India Infoline
Bullish on these 2 stocks in defence sector: Sanjiv Bhasin, India Infoline … sentiment.? The big-bang acquisition by Aurobindo Pharma will bring it closer to Sun Pharma. Aurobindo Pharma has a turnover of $2 billion and …
-
Bullish on these 2 stocks in defence sector: Sanjiv Bhasin, India Infoline
Bullish on these 2 stocks in defence sector: Sanjiv Bhasin, India Infoline … sentiment.? The big-bang acquisition by Aurobindo Pharma will bring it closer to Sun Pharma. Aurobindo Pharma has a turnover of $2 billion and …
-
Sell Cipla, target Rs 455: Jayesh Bhanushali
… Tags Cipla stocks to buy IIFL jayesh bhanushali Pharma stocks IIFL markets …
-
Sell Cipla, target Rs 455: Jayesh Bhanushali
… Tags Cipla stocks to buy IIFL jayesh bhanushali Pharma stocks IIFL markets …
-
Aggressive portfolio: IIFL picks 13 stocks for long term capital appreciation
Aggressive portfolio: IIFL picks 13 stocks for long term capital appreciation … ideas. Investors should focus on a portfolio of around 20 stocks mostly with largecaps for now, while being extremely … on change in the business cycles. Aurobindo Pharma: The growth rate in the US business is …
-
Aggressive portfolio: IIFL picks 13 stocks for long term capital appreciation
Aggressive portfolio: IIFL picks 13 stocks for long term capital appreciation … ideas. Investors should focus on a portfolio of around 20 stocks mostly with largecaps for now, while being extremely … on change in the business cycles. Aurobindo Pharma: The growth rate in the US business is …
-
IIFL's Abhimanyu Sofat makes a case for getting into midcap stocks right now
… IIFL's Abhimanyu Sofat makes a case for getting into midcap stocks right now Most of the midcap … probing could continue to remain a big overhang for Sun Pharma? The issue that we have had with Sun is that … The market will continue to have a bearish view on Sun Pharma. Until and unless, the management gets back and …
-
IIFL's Abhimanyu Sofat makes a case for getting into midcap stocks right now
… IIFL's Abhimanyu Sofat makes a case for getting into midcap stocks right now Most of the midcap … probing could continue to remain a big overhang for Sun Pharma? The issue that we have had with Sun is that … The market will continue to have a bearish view on Sun Pharma. Until and unless, the management gets back and …
-
Do SIP for next 8 weeks; after Oct, expect surge in midcaps: Sanjiv Bhasin
… with positions even in the beleaguered mid and smallcap stocks that have had investors burning their fingers quite … line would be Reliance, UltraTech, IndusInd Bank, L&T, Sun Pharma, Maruti and a Mahindra & Mahindra. In the midcaps, … down sectors like auto, some of the contrarian plays like pharma and some of the sunshine sectors like cement, paints …
-
Do SIP for next 8 weeks; after Oct, expect surge in midcaps: Sanjiv Bhasin
… with positions even in the beleaguered mid and smallcap stocks that have had investors burning their fingers quite … line would be Reliance, UltraTech, IndusInd Bank, L&T, Sun Pharma, Maruti and a Mahindra & Mahindra. In the midcaps, … down sectors like auto, some of the contrarian plays like pharma and some of the sunshine sectors like cement, paints …
-
Keep a SIP for next 10-12 weeks here's a list of 10 large and midcap stocks: Sanjiv Bhasin
… for next 10-12 weeks here's a list of 10 large and midcap stocks: Sanjiv Bhasin One can go against the crowd and start buying cyclical industrial stocks, or go against the crowd and start buying consumption … SIP. The five largecaps are; UltraTech, ITC, Reliance, Sun Pharma and ICICI Bank. Five midcap names would be IGL, Ashok …
-
Keep a SIP for next 10-12 weeks here's a list of 10 large and midcap stocks: Sanjiv Bhasin
… for next 10-12 weeks here's a list of 10 large and midcap stocks: Sanjiv Bhasin One can go against the crowd and start buying cyclical industrial stocks, or go against the crowd and start buying consumption … SIP. The five largecaps are; UltraTech, ITC, Reliance, Sun Pharma and ICICI Bank. Five midcap names would be IGL, Ashok …
-
Now is the time to invest in SBI, Reliance: Abhimanyu Sofat, IIFL
… by ICICI. Going forward, as valuation for a lot of stocks seems to be beaten down, it might be a good time to start buying a bit, going forward. From our perspective, stocks like SBI at current valuation even after today???s … buying at the current level of around Rs 280 odd. Pharma names also doing well. You have a buy call on Dr …
-
Now is the time to invest in SBI, Reliance: Abhimanyu Sofat, IIFL
… by ICICI. Going forward, as valuation for a lot of stocks seems to be beaten down, it might be a good time to start buying a bit, going forward. From our perspective, stocks like SBI at current valuation even after today???s … buying at the current level of around Rs 280 odd. Pharma names also doing well. You have a buy call on Dr …
No search result found
Get the best tips and tricks to save, grow & manage your wealth
- 1/ 2
-